Both in Pharmaceuticals
Emergent Biosolutions vs Canopy Growth
Over the past year EBS returned −35.1% and CGC returned −48.7%; their daily moves had a correlation of 0.10.
EBS −35.1% CGC −48.7%Growth of $1, one year, split-adjusted
| Metric | EBS | CGC |
|---|---|---|
| Price | $6.38 | $0.7130 |
| Market cap | $327.1M | $301.6M |
| Today | −11.14% | −3.06% |
| 1 month | −9.1% | −24.1% |
| 6 months | −27.6% | −37.5% |
| Year to date | −48.4% | −37.5% |
| 1 year | −33.5% | −51.2% |
| Revenue growth (YoY) | +66.3% | +7.8% |
| Gross margin | 58.6% | 27.4% |
| Net margin | −76.9% | −18.0% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 1.3× |
| Net cash | -$442.1M | $67.9M |
| Dividend yield | — | — |
| Volatility (60d) | 96.9% | 41.0% |
| Short % of float | 18.5% | 6.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).